31600-54-1

Basic information

• Product Name: 1-Octanol, 8-(phenylmethoxy)-
• CAS NO: 31600-54-1
• Molecular Formula: C15H24O2
• Molecular Weight: 236.354
• Mol File: 31600-54-1.mol
• Article Data: 37

Chemical Properties

• CAS DataBase Reference: 1-Octanol, 8-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Octanol, 8-(phenylmethoxy)-(31600-54-1)
• EPA Substance Registry System: 1-Octanol, 8-(phenylmethoxy)-(31600-54-1)

Safety Data

• Hazardous Substances Data: 31600-54-1(Hazardous Substances Data)

Upstream product

• 629-41-4 1,8-Octanediol 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 91842-56-7 8-(benzyloxy)octyl 2-tetrahydropyranyl ether 

Downstream Products

• 83515-83-7 (((8-bromooctyl)oxy)methyl)benzene 
• 19117-31-8 N-(phenylthio)-N-(tert-butyl)amine 
• 94600-72-3 N-(phenylsulfinyl)-N-(tert-butyl)amine 
• 106673-33-0 8-benzyloxy-1-octanal 
• 882-33-7 diphenyldisulfane 
• 1250397-58-0 ((8-(10-bromodecyloxy)octyloxy)methyl)benzene 
• 91842-57-8 1-(benzyloxy)-8-(tosyloxy)octane 
• 1046116-41-9 (S)-7-hydroxyhexadecanoic acid 
• 1046116-41-9 (R)-7-hydroxyhexadecanoic acid 

Relevant articles and documents

Composition for controlling pine wood nematode containing benzyloxyalcohol

The present invention relates to a composition for controlling pine nematode comprising a benzyloxyalcohol compound and a method for controlling pine nematode using the same.

LIPID PRODRUGS OF NEUROSTEROIDS

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.

LIPID PRODRUGS OF GLUCOCORTICOIDS AND USES THEREOF

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.